Company: BLUWU
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012302
Chunk: 13

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-05-23
Form: S-1/A
Chunk 13
---
 (or such lower threshold as may be allowed under       
 the Companies Law from time to time);                                                                                                     |
| ● | “sponsor”                                                                                                                                 
 are to Blue Water Acquisition III LLC, Delaware limited liability company which was recently formed to invest in our company, as          
 further discussed under “Sponsor Information” below; and                                                                                  |
| ● | “warrants”                                                                                                                                
 are to our public warrants and private placement warrants.                                                                                |

Any conversion of the Class B ordinary shares described in this prospectus will take effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. Any forfeiture of shares, and all references to forfeiture of shares, described in this prospectus shall take effect as a surrender of shares for no consideration as a matter of Cayman Islands law. Any share dividend described in this prospectus will take effect as a share capitalization as a matter of Cayman Islands law (that is, an issuance of shares from share premium). Unless we tell you otherwise, the information in this prospectus assumes that the underwriters will not exercise their over-allotment option.

| 2 |

Our Company We are a blank check company incorporated on November 1, 2024 as a Cayman Islands exempted company with no material operations of our own and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on high-potential companies in the biotechnology, healthcare and technology sectors. Our mission is to leverage our management team’s extensive expertise and deep industry connections to drive transformative advancements and generate substantial returns for our investors. Investment Focus We are strategically positioned to capitalize on the immense opportunities within the biotechnology, healthcare and technology sectors. With a seasoned team, extensive industry experience and a disciplined investment approach, we are committed to creating value for our investors while fostering the next generation of industry leaders. Biotechnology and Healthcare The biotechnology and healthcare sectors are experiencing rapid growth fueled by innovations in drug discovery, personalized medicine, medical devices and telemedicine. We intend to target companies that are leading the charge in developing